Mesoblast Limited vs Marathon Petroleum Corp — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Marathon Petroleum Corp trades at $334.42 (market cap $94.48B). The key difference: Marathon Petroleum Corp is far larger — about 42.8× Mesoblast Limited's market cap, and Marathon Petroleum Corp pays a 1.19% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | MPC | |
|---|---|---|
Market Cap | $2.21B | $94.48B |
Sector | Technology | Energy |
52-Week High | $20.96 | $336.42 |
52-Week Low | $12.88 | $159.11 |
Enterprise Value | $2.21B | $121.00B |
Dividend Yield | — | 1.19% |
Trailing returns across standard periods
Latest headlines on both assets
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.
Read more on MPC →